Table 4

Outcomes of sensitivity analysis

CombinationsEffectiveness (E) %C′C′/EΔC′/ΔE
CEA+CA12575.8578.31.0323010
CEA+CA21177.03118.81.54232934.42736
CA50+CA21175.20139.51.855049−94.1767
CEA+CA50+CA12584.08127.81.5199926.015012
CEA+CA50+CA21188.27168.31.9066577.246567
CEA+CA125+CA21184.86168.31.9833659.993564
CA50+CA125+CA21183.651892.25936214.18877
CEA+CA50+CA125+CA21192.27217.82.3605318.497098
CEA+NSE+SCC76.82176.42.296412101.6071
CEA+NSE+CA21184.08176.42.0980211.92084
CEA+SCC+CA21183.75208.82.49311216.51739
NSE+SCC+CA21176.19237.63.118397464.4556
CEA+NSE+SCC+CA21188.74266.43.00205314.59352
  • CA50, cancer antigen-50; CEA, carcinoembryonic antigen; NSE, neuron-specific enolase; SCC, squamous cell carcinoma antigen.